Summary
- Current Price
- As of today, CRSP price is $49.99, down -2.78% in the most recent trading session on
- Current Price All-Time High
- CRSP price is currently -77.30% below its historical high of $220.20 set on
- Market Cap
- CRSP current market cap is $5B, down -16.91% year-over-year
- Revenue
- CRSP current annual revenue is $3.51M, down -90.59% year-over-year
- Next Earnings
- As of today, the next earnings release for CRSP has not been scheduled
Profile
| Metric | Value |
|---|---|
| Full Name | CRISPR Therapeutics AG |
| Ticker | NASDAQ: CRSP |
| Exchange | NASDAQ |
| Sector | Healthcare |
| Industry | Biotechnology |
| Country | Switzerland |
| IPO | |
| Indexes | Not included |
| Website | crisprtx.com |
| Employees | 393 |
Key Metrics
| Metric | Value | Date |
|---|---|---|
| Price | $49.99 | |
| Price, 1D Change | -2.78% | |
| $5B | ||
| - | ||
| - | ||
| 1.90 | ||
| $3.51M | ||
| Revenue, 1Y Change | -90.59% | |
| -$6.47 | ||
| EPS, 1Y Change | -48.97% |
Chart
SUGGESTED SERIES
Events
| Metric | Value | Date |
|---|---|---|
| Next Earnings | N/A | |
| Last Qtr. Earnings | ||
| Last Ann. Earnings | ||
| Last Ex-Dividend | N/A | N/A |
| Next Ex-Dividend | N/A | N/A |
| Last Split | N/A | N/A |
| Next Split | N/A | N/A |
| Last Ticker Change | N/A | N/A |
| Next Ticker Change | N/A | N/A |
🔒 Log In To Unlock Full Data
Estimates
| Metric | Value | Date |
|---|---|---|
| -$6.47 | ||
| EPS Estimate | -$4.45 | N/A |
| EPS Est. Change | +31.24% | N/A |
| $3.51M | ||
| Revenue Estimate | $40.44M | N/A |
| Revenue Est. Change | +1,052.09% | N/A |
| Current Price | $49.99 | |
| Price Target | $80.00 | - |
| Price Tgt. Change | +60.03% | - |
🔒 Log In To Unlock Full Data
EPS
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| -$5.12 | -$4.34 | +15.15% | |
| -$6.17 | -$6.47 | -4.87% | |
| -$4.45 | N/A | +31.24% | |
| -$3.55 | N/A | +45.05% |
Revenue
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| $13.93M | $37.31M | +167.84% | |
| $6.12M | $3.51M | -42.66% | |
| $40.44M | N/A | +1,052.09% | |
| $153.97M | N/A | +4,286.59% |
🔒 Log In To Unlock Full Data
Performance
Technicals
| Metric | Value | Date |
|---|---|---|
| Current Price | $49.99 | |
| $52.86 | ||
| $54.00 | ||
| $53.23 | ||
| $52.80 | ||
| -$0.66 | ||
| 1.90 | ||
| $2.64 | ||
| 44.01 | ||
| 50.58% |
Dividends
| Metric | Value | Date |
|---|---|---|
| - | N/A | |
| Upcoming | N/A | N/A |
| - | ||
| - | ||
| $0.00 | ||
| 0.00% |
🔒 Log In To Unlock Full Data
Income & Profitability
| Metric | Value | Date |
|---|---|---|
| $3.51M | ||
| -$6.47 | ||
| -$229.45M | ||
| -6,537.01% | ||
| -$568.32M | ||
| -16.19% | ||
| -$581.60M | ||
| -16.57% | ||
| -$548.84M |
🔒 Log In To Unlock Full Data
Financial Health
| Metric | Value | Date |
|---|---|---|
| 0.11 | ||
| 13.32 | ||
| 13.32 | ||
| - | ||
| 3 | ||
| 7.39 |
Valuations
| Metric | Value | Date |
|---|---|---|
| - | ||
| 360.94 | ||
| 2.77 | ||
| -6.34 | ||
| - | N/A |
Balance Sheet
| Metric | Value | Date |
|---|---|---|
| $1.92B | ||
| $1.98B | ||
| $2.27B | ||
| $1.99B | ||
| $343.43M | ||
| $149.12M | ||
| $206.75M | ||
| $18.58M | ||
| $11.14M |
Expenses
| Metric | Value | Date |
|---|---|---|
| $585.11M | ||
| $338.87M | ||
| $232.96M | ||
| $73.54M | ||
| $19.48M | ||
| $0.00 | ||
| $3.63M |
Cash Flow
| Metric | Value | Date |
|---|---|---|
| -$345.01M | ||
| -$31.81M | ||
| $426.03M | ||
| $914.00K | ||
| -$345.93M |
Recent analyst updates
| Metric | Value | Date |
|---|---|---|
| UBS | ||
| Needham | → | |
| Citizens | → | |
| Citizens | → | |
| Citigroup | → | |
| HC Wainwright & Co. | → | |
| Citizens | → | |
| Bernstein | → | |
| Citigroup | → | |
| Piper Sandler | → |
Analyst sentiment
Institutional ownership
Screeners with CRSP
FAQ
- What is the ticker symbol for CRISPR Therapeutics AG?
- The ticker symbol for CRISPR Therapeutics AG is NASDAQ:CRSP
- Does CRISPR Therapeutics AG pay dividends?
- No, CRISPR Therapeutics AG does not pay dividends
- What sector is CRISPR Therapeutics AG in?
- CRISPR Therapeutics AG is in the Healthcare sector
- What industry is CRISPR Therapeutics AG in?
- CRISPR Therapeutics AG is in the Biotechnology industry
- What country is CRISPR Therapeutics AG based in?
- CRISPR Therapeutics AG is headquartered in Switzerland
- When did CRISPR Therapeutics AG go public?
- CRISPR Therapeutics AG initial public offering (IPO) was on October 19, 2016
- Is CRISPR Therapeutics AG in the S&P 500?
- No, CRISPR Therapeutics AG is not included in the S&P 500 index
- Is CRISPR Therapeutics AG in the NASDAQ 100?
- No, CRISPR Therapeutics AG is not included in the NASDAQ 100 index
- Is CRISPR Therapeutics AG in the Dow Jones?
- No, CRISPR Therapeutics AG is not included in the Dow Jones index
- When was CRISPR Therapeutics AG last earnings report?
- CRISPR Therapeutics AG's most recent earnings report was on November 2, 2026
- When does CRISPR Therapeutics AG report earnings?
- The date for CRISPR Therapeutics AG's next earnings report has not been announced yet
Data Sources & References
- CRSP Official Website www.crisprtx.com
- Most Recent Annual Report (10-K) www.sec.gov/Archives/edgar/data/1674416/000119312526048957/0001193125-26-048957-index.htm
- CRSP Profile on Yahoo Finance finance.yahoo.com/quote/CRSP
- CRSP Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/crsp